Osama Rahma
Medical Oncology · Boston, MANPI 1730172149
Payments from drug & device makers
Across 1,215 payments — averaging $3660.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$2.7M
- Incyte Corporation$863K
- Macrogenics, Inc.$295K
- Novartis$192K
- Roche Products Limited$174K
- Amgen$107K
- plus $147K from 9 others
Across 5 payments — averaging $6188.95 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Macrogenics, Inc.$30K
- F. Hoffmann-la Roche AG$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 19 | $2,670,458 |
| Incyte Corporation | 1,061 | $862,559 |
| Macrogenics, Inc. | 69 | $294,600 |
| Novartis | 3 | $191,818 |
| Roche Products Limited | 5 | $173,923 |
| Amgen | 6 | $107,029 |
| EMD Serono, Inc. | 18 | $67,524 |
| Genentech, Inc. | 9 | $57,569 |
| F. Hoffmann-la Roche AG | 13 | $8,845 |
| Swedish Orphan Biovitrum AB | 2 | $4,831 |
| GSK | 1 | $3,399 |
| Bayer | 3 | $2,017 |
| Boehringer Ingelheim RCV GmbH & Co KG | 1 | $1,600 |
| Hoffmann-la Roche Limited | 4 | $1,055 |
| E.r. Squibb & Sons, L.L.C. | 1 | $50 |
How this compares
$4,447,277 in reported general payments places this provider in the 85th percentile of 308 medical oncology providers in Massachusetts.
Other medical oncology in Boston
- Otto MetzgerBoston$141.9M
- Suzanne GeorgeBoston$88.5M
- Pasi Antero JanneBoston$67.2M
- Erica MayerBoston$51.8M
- Toni ChoueiriBoston$28.3M
- Laura SpringBoston$22.9M
- James ClearyBoston$18.8M
- Marlise LuskinBoston$18.7M
- Ana Garrido-CastroBoston$18M
- Jacob LaubachBoston$17.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.